TRLs in Pharmaceutical Development: A Detailed Walkthrough
In the realm of pharmaceuticals, Technology Readiness Levels (TRLs) serve as a critical pathway from initial research to the marketing of a new drug. Each level represents a significant step in the journey of drug development. Below is a detailed explanation of each TRL in the context of pharmaceuticals.
- TRL1 - Findings Reviewed: This initial stage involves reviewing existing research and findings, laying the groundwork for new pharmaceutical developments.
- TRL2 - Research Idea: At this stage, researchers formulate a specific research idea or hypothesis based on the initial findings.
- TRL3 - Design Proof of Concept: Scientists design experiments to prove the concept of the proposed pharmaceutical treatment.
- TRL4 - Demonstrate Proof of Concept: The proof of concept is demonstrated through initial laboratory experiments, validating the research idea.
- TRL5 - Pilot Drug Produced: A pilot version of the drug is produced, typically in small quantities, for preliminary testing.
- TRL6 - Phase 1 Clinical Trials: The drug enters Phase 1 clinical trials, where it is tested on a small group of people to evaluate its safety, determine a safe dosage range, and identify side effects.
- TRL7 - Phase 2 Clinical Trials: In Phase 2 trials, the drug is given to a larger group of people to see if it is effective and to further evaluate its safety.
- TRL8 - New Drug Registration: After successful clinical trials, the drug goes through the process of registration, where it is thoroughly reviewed and approved by regulatory authorities for market release.
- TRL9 - Drug Distributed and Marketed: The final stage where the drug is fully approved, manufactured on a large scale, distributed, and marketed to the public.
Pharmaceutical TRLs
The progression of pharmaceuticals from TRL1 to TRL9 is a complex journey from theoretical research to a marketable drug.
